In The Headlines Home

FDA Approves New Opioid Addiction Treatment

Friday, July 5th, 2013

Take a Pill note The U.S. Food and Drug Administration has approved a new drug to treat opioid addiction, according to Reuters. The drug, Zubsolv, is made by Swedish pharmaceutical company Orexo. According to the company, it is preferable to Suboxone because it uses less drug for the same effect. Zubsolv dissolves under the patient’s tongue and has a menthol flavor that patients preferred.

This year, the FDA approved generic versions of Suboxone and rejected a drug that is similar to Zubsolv but is implanted under the patient’s skin. Opioid addiction treatments Subuxone and Subutex generated $1.3 billion in sales in 2012, and Orexo said it expected to generate at least $500 million in peak sales of Zubsolv. The drug is expected to launch in the United States this September.

If you or a loved one needs help for a substance abuse issue, Phoenix House is here for you. Email us or call today at 1 888 671 9392.

Source: Reuters U.S. FDA approves Orexo drug to treat opioid addiction

Share this page: Print this page:

In The Headlines Home

Comments are closed.